Try our Advanced Search for more refined results
Health
-
April 06, 2026
Paperwork Lapse Led To 'Horrific' Family Slayings, Jury Told
Counsel for slain family members of a mentally ill man who murdered them after being discharged from a psychiatric ward asked a Philadelphia jury on Monday to impose a "substantial" verdict against a healthcare management company for allegedly not submitting paperwork that would have stopped him from buying a gun.
-
April 06, 2026
1st Circ. Suggests It May Resurrect AdTech Wiretap Case
A panel of the First Circuit appeared receptive Monday to reinstating federal wiretap claims leveled against a Massachusetts healthcare system over its use of online tracking tools, despite arguments that such a ruling could cripple the industry amid an influx of similar cases nationwide.
-
April 06, 2026
Full Fed. Circ. Urged To Course Correct On Design Patent Test
The full Federal Circuit needs to return design patent infringement to a similarities-focused test, rather than one looking at differences between designs, massage device-maker Range of Motion Products LLC said in a bid to revive its suit against Armaid Co.
-
April 06, 2026
Cleary FCA Task Force Head On Enforcement Trends To Watch
Former U.S. Attorney for the Eastern District of New York Breon Peace, who now leads a False Claims Act task force at Cleary Gottlieb Steen & Hamilton LLP, is predicting a continued surge in enforcement as the Trump administration wields the law in new ways.
-
April 06, 2026
NJ Pharmacy Co. Sued Over Nursing Home Data Exposure
A New Jersey pharmacy for long-term care facilities is facing a proposed nationwide class action alleging it failed to safeguard highly sensitive patient information later accessed by cybercriminals, according to a complaint filed in federal court.
-
April 06, 2026
Mass. Justices Hint Insurer Owes Defense In Doc's Discipline
An allegation that a Massachusetts doctor prescribed addictive medications to manipulate a patient into a sexual relationship could be enough to trigger a malpractice insurer's duty to defend him in a disciplinary proceeding launched years later over other alleged misconduct, justices on the state's highest court hinted Monday.
-
April 06, 2026
Pfizer Failed To Warn Of Depo-Provera Cancer Risk, Suit Says
A Georgia woman who alleged she developed a brain tumor after taking the contraceptive drug Depo-Provera sued Pfizer in federal court, claiming the company failed to warn American patients about the danger even though it does so on warning labels in the European Union.
-
April 06, 2026
WilmerHale Adds Regulatory Atty From Mayer Brown In DC
WilmerHale announced Monday it has hired a veteran U.S. Food and Drug Administration and life sciences regulatory attorney from Mayer Brown LLP.
-
April 06, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured a mix of high-profile corporate disputes, insider trading allegations, contract fights and significant rulings shaping fiduciary duty and deal litigation.
-
April 06, 2026
Cooley, Wilson Sonsini Steer Neurocrine's $2.9B Soleno Buy
Neurocrine Biosciences has agreed to acquire biotechnology company Soleno Therapeutics for about $2.9 billion in cash, in a deal advised by Cooley LLP and Wilson Sonsini Goodrich & Rosati PC, the companies said on Monday.
-
April 06, 2026
4 Firms Guide Healthcare REIT's Early IPO Steps
National Healthcare Properties filed Monday for an initial public offering in which the healthcare real estate investment trust preliminarily estimated it could raise $100 million, advised by Paul Weiss Rifkind Wharton & Garrison LLP and two other firms.
-
April 06, 2026
Justices To Mull Courts' Authority To Hear Vets' Benefits Suits
The U.S. Supreme Court on Monday agreed to review a U.S. Army veteran's suit challenging the limit on disability benefits available to him as someone convicted of a felony and sentenced to a lengthy prison term, after the Eleventh Circuit dismissed his claims.
-
April 03, 2026
Case-By-Case Guide As Justices Eye Landmark Pharma Law
Drugmakers and prominent allies are inundating the U.S. Supreme Court with calls to scrutinize Medicare's new power to slash payments by tens of billions of dollars, and the justices look poised to take up or turn down a fistful of legal challenges in one fell swoop.
-
April 03, 2026
Wash. DOC Inks Deal Over Trans Treatment In Facilities
The Washington State Department of Corrections will start improving conditions for transgender, intersex and nonbinary people in its facilities and submit to yearly monitoring, according to a settlement agreement between the agency and a nonprofit in the state.
-
April 03, 2026
Colo. Doctor Says Centura Lacks Proof For Mitigation Defense
A doctor who claims Centura Health recruited him for an in-house position and took back a job offer after he disclosed that he was suffering symptoms of burnout asked a judge in Colorado federal court to toss one of the healthcare company's affirmative defenses.
-
April 03, 2026
Anthem, Wells Fargo Say Patients Received All Benefits Owed
Insurers urged a Colorado federal judge to allow them to escape claims from a mental health and substance use treatment facilities operator's lawsuit, alleging the facility lacks standing to bring claims under federal benefits and mental health parity laws.
-
April 03, 2026
States Warn Of Executive Overreach In $100K H-1B Fee Fight
A group of 20 states challenging the Trump administration's $100,000 fee on H-1B visa petitions slammed its position that the policy isn't reviewable, telling a Massachusetts federal court the government would essentially have a blank check to usurp congressional authority under its rationale.
-
April 03, 2026
Schneider Wallace Loses Bid For Bigger Piece Of $75M Fee
A California federal magistrate judge on Friday rejected Schneider Wallace Cottrell Kim LLP's bid to increase its cut of a $75.4 million fee award for representing plaintiffs in a $228.5 million Sutter Health antitrust deal, saying lead counsel Constantine Cannon LLP's allocation of $1.4 million to Schneider Wallace was fair.
-
April 03, 2026
Legislative Update: Cannabis And Psychedelics Bill Roundup
State lawmakers in Delaware and West Virginia advanced legislation to more tightly regulate kratom products, Missouri and Kentucky legislators considered bills to fund research into the therapeutic uses of the psychedelic ibogaine, and Idaho's Legislature came together to urge voters to reject a medical marijuana legalization proposal that could be on the ballot this November. Here are the major moves in cannabis and psychedelics legislation from the past week.
-
April 03, 2026
Bradley Arant Launches Medical Office Real Estate Team
Bradley Arant Boult Cummings LLP has launched a team focused on medical office buildings real estate led by partners in Nashville, Tennessee, and Dallas.
-
April 03, 2026
Northwestern Can't Escape ERISA Fight Over Health Offerings
An Illinois federal court refused to toss a proposed class action against Northwestern University alleging excessive employee healthcare costs violated federal benefits law, concluding ex-workers had sufficiently backed up their allegations that an expensive plan option breached fiduciary duties.
-
April 03, 2026
Law360 Announces The Members Of Its 2026 Editorial Boards
Law360 is pleased to announce the formation of its 2026 Editorial Advisory Boards.
-
April 03, 2026
Ga. Urology Network To Pay $14M To Resolve FCA Case
An Atlanta urology network and its founder will pay $14 million to settle allegations that they billed Medicare and Medicaid for medically unnecessary procedures, ranging from ultrasounds to endoscopic exams, according to an announcement by federal and Georgia state prosecutors.
-
April 03, 2026
Aetna Escapes COVID Testing Payment Suit In Calif.
A Nebraska testing laboratory failed to prove that Aetna underpaid more than $53 million for COVID-19 testing services, a California federal judge has ruled, dismissing the lab's federal racketeering and state law claims against the insurer but leaving the door open to an amended suit.
-
April 03, 2026
Greenberg Traurig Adds Former Healthcare GC In Dallas
Greenberg Traurig LLP has boosted its healthcare and U.S. Food and Drug Administration practice with a shareholder in Dallas who brings substantial in-house experience, most recently serving as general counsel to ophthalmology administrative services provider Sight Growth Partners.
Expert Analysis
-
Wage-Based H-1B Rule Amplifies Lottery Risks For Law Firms
Under the wage-based H-1B lottery rule taking effect Feb. 27, law firms planning to hire noncitizen law graduates awaiting bar admission should consider their options, as the work performed by such candidates may sit at the intersection of multiple occupational classifications with differing chances of success, says Jun Li at Reid & Wise.
-
Series
Judges On AI: Practical Use Cases In Chambers
U.S. Magistrate Judge Allison Goddard in the Southern District of California discusses how she uses generative artificial intelligence tools in chambers to make work more efficient and effective — from editing jury instructions for clarity to summarizing key documents.
-
Assessing Compliance Risks Around TrumpRx Participation
As there are novel compliance obligations and potential political opposition related to the new TrumpRx online drug platform, companies intending to participate on the site should consider the pressure points that are likely to draw enforcement scrutiny, say attorneys at Sheppard.
-
California's New Privacy Laws Demand Preparation From Cos.
An increase in breach disclosures is coinciding with California's most comprehensive privacy and artificial intelligence legislation taking effect, illustrating the range of vulnerabilities organizations in the state face and highlighting that the key to successfully managing these requirements is investing in capabilities before they became urgent, says Camilo Artiga-Purcell at Kiteworks.
-
Series
Trail Running Makes Me A Better Lawyer
Navigating the muddy, root-filled path of trail marathons and ultramarathons provides fertile training ground for my high-stakes fractional general counsel work, teaching me to slow down my mind when the terrain shifts, sharpen my focus and trust my training, says Eric Proos at Next Era Legal.
-
Predicting Actual Impact From CDC's New Vaccine Guidance
Recent federal changes to the childhood immunization schedule, reducing the number of vaccine recommendations from 18 to 11, do not automatically create enforceable obligations for parents, schools or healthcare providers, but may spur litigation and other downstream effects on school policies and state guidelines, says Mehdi Sinaki at Michelman & Robinson.
-
AI Scientific Discovery Order Implications For Life Sciences
President Donald Trump's November executive order establishing a government effort to use artificial intelligence to accelerate scientific discovery has the potential to leverage significant federal resources and data to support research, drug and device approvals, and AI model training in the life sciences sector, say attorneys at Hogan Lovells.
-
What Rescheduling Means For Cannabis Labels, Marketing
The proposed reclassification of cannabis is expected to bring heightened scrutiny of labeling, advertising and marketing from the U.S. Food and Drug Administration and the Federal Trade Commission, but the brands that tighten evidence, standardize operations and professionalize marketing controls now will see fewer surprises and better outcomes, say attorneys at Wilson Elser.
-
What's At Stake In Possible Circuit Split On Medicaid Rule
A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.
In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.
-
Unpacking Dormant Commerce Clause Cannabis Circuit Split
Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.
-
Remote Patient Monitoring Is At Regulatory Inflection Point
With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.
-
Texas AG Wields Consumer Protection Law Against Tech Cos.
Texas Attorney General Ken Paxton has targeted technology companies using the Texas Deceptive Trade Practices Act, a broadly worded statute that gives the attorney general wide latitude to pursue claims beyond traditional consumer protection, creating unique litigation risks, say attorneys at Yetter Coleman.
-
Utah's AI Prescription Renewal Pilot Could Inform Policy
Utah recently became the first state to approve an artificial intelligence system for autonomously renewing certain prescription medicines, providing a test case for how regulators may be able to draw boundaries between administrative automation and medical judgment, say Jashaswi Ghosh at Holon Law Partners and Bryant Godfrey at Foley Hoag.